Prot# Hx-CD4-008: An Open-Label Therapeutic Exploratory Clinical Trial of HuMax-CD4, A Fully Human Monoclonal Anti-CD4 Antibody, in Patients with Advanced Stage (IIA-IVB) Cutaneous T-Cell Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date11/13/03 → 3/30/04

Funding

  • Genmab A/S (Hx-CD4-008)